Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.
Open accessAbstract
OBJECTIVES: To assess and compare the prevalence of parkinsonism and Parkinson's disease in five European populations that were surveyed with similar methodology and diagnostic criteria. METHODS: Joint analysis of five community surveys--Gironde (France), eight centres in Italy, Rotterdam (The Netherlands), Girona (Spain), and Pamplona (Spain)--in which subjects were screened in person for parkinsonism. Overall, these surveys comprised 14,636 participants aged 65 years or older. RESULTS: The overall prevalence (per 100 population), age adjusted to the 1991 European standard population, was 2.3 for parkinsonism and 1.6 for Parkinson's disease. The overall prevalence of parkinsonism for the age groups 65 to 69, 70 to 74, 75 to 79, 80 to 84, and 85 to 89 years was respectively, 0.9, 1.5, 3.7, 5.0, and 5.1. The corresponding age specific figures for Parkinson's disease were 0.6, 1.0, 2.7, 3.6, and 3.5. After adjusting for age and sex, the prevalence figures did not differ significantly across studies, except for the French study in which prevalence was lower. Prevalence was similar in men and women. Overall, 24% of the subjects with Parkinson's disease were newly detected through the surveys. CONCLUSIONS: Prevalence of both parkinsonism and Parkinson's disease increased with age, without significant differences between men and women. There was no convincing evidence for differences in prevalence across European countries. A substantial proportion of patients with Parkinson's disease went undetected in the general population.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The prevalence of Parkinson's disease increases with advancing age both for men and women with no decreases at higher ages.
“The prevalence increases with advancing age both for men and women with no decreases at higher ages (De Rijk et al. 1997).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as De Rijk et al. 1997
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- Zhang Z, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuro- epidemiology 1993;12:195-208.
- Breteler MMB, Alperovitch A, Lopez-Pousa S, Manubens- Bertran JM, Rocca WA. EUROPARKINSON: a European concerted action on incidence and risk factors for Parkinson's disease [abstract]. Neuroepidemiology 1993;12:17.
- Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 1994;90:111-5.
- Maggi S, Zucchetto M, Grigoletto F, Baldereschi M, Candelise L, Scarpini E, et al. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging Clin Exp Res 1994;6:463-71.
- de Rijk MC, Breteler MMB, Graveland GA, Ott A, Grobbee DE, van der Meche FGA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995;45:2143-6.
- Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 1992;42:1901-7.
- Grigoletto F, Anderson DW, Rocca WA, Meneghini F, Morgante L, Reggio A, et al. Attrition and use of proxy respondents and auxiliary information in the Sicilian Neuroepidemiologic Study. Am J Epidemiol 1994;139: 219-28.
- Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-5.
- Barucha NE, Barucha EP, Barucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson's disease in the Parish Community of Bombay, India. Arch Neurol 1988; 45:1321-3.
- Marttila RJ, Rinne UK. Epidemiology of Parkinson's dis- ease in Finland. Acta Neurol Scand 1976;53:81-102.
- Rosati G, Granieri E, Pinna L, Aiello I, Tola R, De Bastiani P, et al. The risk of Parkinson disease in Mediterranean people. Neurology 1980;30:250-5.
- D'Alessandro R, Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli D. Prevalence of Parkinson's disease in the Republic of San Marino. Neurology 1987; 37:1679-82.
- Okada K, Kobayashi S, Tsunematsu T. Prevalence of Parkinson's disease in Izumo City, Japan. Gerontology 1990;36:340-4.
- Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson's disease in a Scottish city. BMJ' 1986;292:534-6.
- Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang M, Cote U, et al. A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol 1992;49:492-7.
- Mayeux R, Marder K, Cote U, Denaro J, Hemenegildo N, Mejia H, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northem Manhattan. AmJ Epidemiol 1995;142:820-7.
- Ho SC, Woo J, Lee CM. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology 1989;39: 1314-8.
- Schoenberg BS, Osuntokun BO, Adeuja AOG, Bademosi 0, Nottidge V, Anderson DW, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988;38:645-6.
- Lux WE, Kurtzke JF. Is Parkinson's disease acquired? Evidence from geographic comparison with multiple scle- rosis. Neurology 1987;37:467-71.
- Kurtzke JF, Goldberg ID. Parkinsonism death rates by race, sex, and geography. Neurology 1988;38:1558-61.
- Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, et al. Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-21.
Cited by
Sorted by citations
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works
Self-citationThe prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188 · see citing works
The clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410 · see citing works
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266 · see citing works
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works
The epidemiology of Parkinson's disease
Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., & Tanner, C. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01419-8 · Cited by 967 · see citing works
Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526 · see citing works
Self-citationTamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Oryan, S., Mafi, A., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.018 · Cited by 398 · see citing works
RetractedRisk tables for parkinsonism and Parkinson’s disease
Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00425-5 · Cited by 377 · see citing works
Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J., & Schumacker, P. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.045 · Cited by 236 · see citing works
Gender differences in Parkinson’s disease: A clinical perspective
Georgiev, D., Hamberg, K., Hariz, M., Forsgren, L., & Hariz, G.-M. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12796 · Cited by 220 · see citing works
The role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism
Kumar, H., Lim, H.-W., More, S. V., Kim, B.-W., Koppula, S., Kim, I. S., & Choi, D.-K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810478 · Cited by 212 · see citing works
Constantinescu, G., Theodoros, D., Russell, T., Ward, E., Wilson, S., & Wootton, R. (2011) · International Journal of Language & Communication Disorders · doi:10.3109/13682822.2010.484848 · Cited by 192 · see citing works
Systematic review of the prevalence and incidence of Parkinson's disease in Asia
Muangpaisan, W., Hori, H., & Brayne, C. (2009) · Journal of Epidemiology · doi:10.2188/jea.je20081034 · Cited by 185 · see citing works
Yanamandra, K., Gruden, M. A., Casaite, V., Meskys, R., Forsgren, L., & Morozova-Roche, L. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018513 · Cited by 171 · see citing works
Risk factors for parkinson’s disease: The leisure world cohort study
Paganini-Hill, A. (2001) · Neuroepidemiology · doi:10.1159/000054770 · Cited by 159 · see citing works
Hook, P. W., McClymont, S. A., Cannon, G. H., Law, W. D., Morton, A. J., Goff, L. A., & McCallion, A. S. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.02.001 · Cited by 136 · see citing works
Beuter, A., Lefaucheur, J.-P., & Modolo, J. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.01.006 · Cited by 107 · see citing works
Louis, E. D., Thawani, S. P., & Andrews, H. F. (2009) · Neuroepidemiology · doi:10.1159/000195691 · Cited by 105 · see citing works
Padel, T., Özen, I., Boix, J., Barbariga, M., Gaceb, A., Roth, M., & Paul, G. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.002 · Cited by 70 · see citing works
Gröger, A., & Berg, D. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0873-0 · Cited by 34 · see citing works
- Authors
- de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A.
- Affiliations
- Erasmus MC (NL)
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1997-01-01
- Volume
- 62
- Issue
- 1
- Pages
- 10-15
- ISSN
- 0022-3050 (ISSN-L)
- PMC
- PMC486688
- OpenAlex
- W2137849205
- Cited by
- 833
- References
- 0
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 32 · 2020: 21 · 2019: 28 · 2018: 35 · 2017: 36 · 2016: 38 · 2015: 31 · 2014: 34 · 2013: 38 · 2012: 34
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, parkinsonism, prevalence, older adults, age-specific prevalence, sex differences, underdiagnosis, community-based screening, European populations
- MeSH terms
- Aged, Aged, 80 and over, Europe, Female, Humans, Male, Middle Aged, Parkinson Disease, Prevalence, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
